Lung Cancer Update April 2021
Breast-Cancer-Update-2021
detecting metastases with psma pet in prostate cancer
/by In, , , Tags:, , , , , , , , , , , ,

Detecting metastases with PSMA-PET in prostate cancer

Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.

ASCO 2020 ASCO20 virtual meeting NSCLC SCLC lung cancer breast cancer hepatocellular cancer HCC colorectal cancer CRC
Combination therapy with a novel agent, albuvirtide, in hospitalised AIDs patients
/by In, , Tags:, , , , , ,

Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients

Delayed therapy start and antiretroviral therapy (ART) resistance are two common issues affecting up to 33% and 17% of patients infected with human immunodeficiency virus (HIV), respectively. These patients commonly present with higher viral loads, lower CD4 T-cell count, and complications such as infections requiring acute treatment. For those patients presenting with acquired immunodeficiency syndrome (AIDS) or those who have breakthrough HIV, and who present with opportunistic infections and comorbidities requiring hospitalisation, ART treatments are limited.

CANCERINFORMER
BREAKING

Therapeutic Areas

Or, sign up for our newsletter


Therapeutic Areas

U.S. FDA approved immunecheckpoint inhibitors U.S. FDA approved immunotherapies for cancer U.S. FDA approved immunotherapies for cancer
asco guidelines for the use of systemic therapies in advanced hepatocellular cancer
Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions
/by In, Tags:, , , , , , , , ,

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Patient blood management (PBM) is a multimodal, multidisciplinary, patient-centred strategy aimed at minimising the use of blood products and improving patient outcomes. It has shown to minimise perioperative bleeding, perioperative morbidity, mortality and duration of hospitalisation. There are three main pillars of PBM – improving red cell mass, minimising blood loss, and managing anaemia.

Evidence-of-SARS-CoV2-in-heart-cells

Copy link
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog